국내 요양병원 고위험의약품 목록 도출 = Developing National Level High Alert Medication Lists for Long-Term Care Patients

다국어 초록 (Multilingual Abstract)

Background : High-alert medications (HAMs), the prominent cause of medication harm, can have serious consequences for patients. They should be developed and managed according to institutions. However, HAMs for long-term care (LTC) hospitals presented in hospital accreditation standards in Korea are based on the list of HAMs of acute care hospitals. The aim of this study was to develop a national-level list of high-alert medications for LTC hospitals.
Methods : A combined strategy of literature review, epidemiological data analysis of medication error-related incidents, medication utilization, and a survey of expert opinions was applied. We identified candidates of HAMs for LTC from the Institute for Safe Medication Practices (ISMP) and the list of Korean hospital accreditation standards. We analyzed the following database to identify medication error and utilization: the Korea Patients Safety Reporting & Learning System (KOPS) and Korea Adverse Event Reporting System (KAERS), and sample data from national claims. Seven experts working in LTC hospitals evaluated the adequacy and priority of candidate medications.
Results : We derived a final list of 16 high-alert medications, including six essential medications (insulin vials, heparin and low molecular weight heparins, hypertonic sodium chloride solutions, concentrated potassium injections, concentrated magnesium injections, and oral chemotherapeutic agents) and 10 optional medications (insulin pens, oral anticoagulants, immunosuppressants, parenteral nutrients for central veins, parenteral chemotherapeutic agents, parenteral benzodiazepines, contrast agents, phenytoin, epinephrine injections, and oral digoxin).
Conclusion : We developed a list of high-alert medications for LTC settings at the national level, which may improve medication use and safety in patients who receive LTC.

참고문헌 (Reference)

1 김경숙, "요양병원 인증 2주기 당면과제 및 해결방안" 한국병원경영학회 21 (21): 65-70, 2016

2 한지민 ; 허규남 ; 이아영 ; 민상일 ; 김현지 ; 백진희 ; 노주현 ; 김수인 ; 김지연 ; 이해원 ; 조은주 ; 아영미 ; 이주연, "국내 급성기 의료기관 고위험 의약품 목록 도출" 한국임상약학회 32 (32): 116-124, 2022

3 A Sheikh, "The third global patient safety challenge : tackling medication-related harm" 95 (95): 546-, 2017

4 MI Zafar, "Suitability of APINCH highrisk medications use in diabetes mellitus" 867 : 172845-, 2020

5 Korea Institute for Healthcare Accreditation, "Revised geriatric hospital accreditation standards"

6 NM Wilson, "Medication safety in residential agedcare facilities : a perspective" 1 (1): 11-20, 2010

7 JH Gurwitz, "Incidence and preventability of adverse drug events in nursing homes" 109 (109): 87-94, 2000

8 Institute for Safe Medication Practices, "ISMP List of High-Alert Medications in long-term care (LTC) settings"

9 I Dumitrescu, "High-risk medication in community care : a scoping review" 76 (76): 623-638, 2020

10 Essex Partnership University NHS Foundation Trust, "Formulary and Prescribing Guidelines"

11 MJ Otero, "Developing a list of high-alert medications for patients with chronic diseases" 25 (25): 900-908, 2014

12 ND Barber, "Care homes’ use of medicines study : prevalence, causes and potential harm of medication errors in care homes for older people" 18 (18): 341-346, 2009

13 M Koronkowski, "An Update on Geriatric Medication Safety and Challenges Specific to the Care of Older Adults" 24 (24): 37-40, 2016